U.S. market Closed. Opens in 11 hours 17 minutes

SIOX | Sio Gene Therapies Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2022-09-302022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating ExpensesN/A71.56M42.20M69.17M127.02M213.32M180.50MN/AN/A
Selling, General & AdminN/A18.16M17.29M22.06M39.47M71.91M45.72M56.52MN/A
Research & DevelopmentN/A53.40M24.90M47.11M87.55M141.41M134.78M76.64MN/A
Other Operating ExpensesN/A-39.00K10.36M1.36M5.62M211.00KN/AN/AN/A
Operating IncomeN/A-72.27M-34.30M-67.81M-127.02M-213.32M-180.50M-133.16MN/A
Other Expenses / IncomeN/A639.00K1.67M-4.38M5.62M211.00K-1.51MN/AN/A
Before Tax IncomeN/A-71.63M-32.64M-72.19M-128.93M-220.65M-182.01M-133.16MN/A
Income Tax ExpensesN/A259.00K-212.00K438.00K133.00K921.00K-1.06M-17.00KN/A
Net IncomeN/A-71.89M-32.42M-72.63M-129.06M-221.57M-180.95M-133.15MN/A
Interest ExpensesN/A27.00K799.00K4.38M7.53M7.54M1.14MN/AN/A
Basic Shares Outstanding73.70M73.21M52.18M24.81M16.10M13.42M12.39M11.81M11.81M
Diluted Shares Outstanding73.70M73.21M52.18M24.81M16.10M13.42M12.39M11.81M11.81M
EBITDAN/A-71.60M-31.84M-64.72M-121.40M-210.02M-180.62M-133.15MN/A
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBITN/A-71.60M-31.84M-67.81M-121.40M-213.11M-180.87M-133.16MN/A
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2022-09-302022-03-312021-03-312020-03-312019-03-312018-03-312017-03-312016-03-312015-03-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙